Review of Studies Comparing Panretinal Photocoagulation and Anti ...

The aim of this review is to briefly discuss and compare the relevant studies and evidence supporting these two treatments.

A decade-long period of comparisons and debates between these two treatment modalities repeatedly favored anti-VEGF over PRP, as studies ...

Anti-VEGF Injections vs. Panretinal Photocoagulation Laser Therapy ...

Our results show more favorable BCVA outcomes with anti-VEGF compared with PRP at 3 months (mean difference [MD] = 2.35 letters; 95% confidence ...

Effectiveness of Panretinal Photocoagulation Plus Intravitreal Anti ...

In the previous study, anti-VEGF monotherapy has been reported to show potential benefits compared to PRP monotherapy. However, anti-VEGF ...

Intravitreal anti-vascular endothelial growth factor versus panretinal ...

Five studies of varying quality met the inclusion criteria (n = 632). The anti-VEGF intervention arm had a mean difference of −0.08 logMAR or 4 Early Treatment ...

Efficacy and safety of pan retinal photocoagulation combined

Eight studies (6 randomized controlled trials and 2 retrospective studies) with 375 eyes were included in this meta-analysis. There were no ...

Anti–Vascular Endothelial Growth Factor Drugs Compared With ...

The results of this analysis suggest that anti-VEGFs are unlikely to be a cost-effective treatment option compared with panretinal ...

Anti-vascular endothelial growth factor injections vs panretinal ...

Our results show more favorable BCVA outcomes with anti-VEGF compared to PRP at 3 months (MD=2.35 letters, 95% CI: 1.18, 3.52, I2=0%) and 12 ...

Intravitreal anti‐vascular endothelial growth factors, panretinal ...

To conduct a systematic review with network meta-analysis (NMA) of randomized clinical trials (RCTs) comparing panretinal photocoagulation (PRP) ...

Review of Studies Comparing Panretinal Photocoagulation and Anti ...

Review of Studies Comparing Panretinal Photocoagulation and Anti-Vascular Endothelial Growth Factor Therapy in the Treatment of Proliferative Diabetic ...

Evaluation of Anti-VEGF and Pan-Retinal Photocoagulation Laser ...

Anti-vascular endothelial growth factor (anti-VEGF) therapy becomes an alternative to avoid the side effects caused by laser therapy. This systematic review ...

Anti-VEGF drugs compared with laser photocoagulation for the ...

Panretinal photocoagulation (PRP) is the primary treatment for PDR. Anti-vascular endothelial growth factor (anti-VEGF) drugs are used to treat ...

Regression of Neovascularization after Panretinal Photocoagulation ...

The studies comparing PRP alone with PRP plus anti-VEGF therapy showed greater reduction of the NV area with combination therapy [27,28,30,31,32,33,35,36,37,39, ...

Mechanistic Evaluation of Panretinal Photocoagulation Versus ...

The difference in AVD between groups at week 52 was 4.0% (95% confidence interval, −0.08, 8.8; P = 0.10). The baseline mean area of retinal nonperfusion of ...

A Comprehensive Meta-Analysis on the Role of Analgesics and Anti ...

Pan-retinal photocoagulation (PRP) is the mainstay of treatment for proliferative diabetic retinopathy (PDR), reducing the risk of severe vision loss.

A comparison between the therapeutic effects of Conbercept ...

Panretinal photocoagulation (PRP) has been used as a classical treatment for PDR for over 40 years. In this procedure, the ischemic regions of ...

A review of anti-VEGF agents for proliferative diabetic retinopathy

Review of Studies Comparing Panretinal Photocoagulation and Anti-Vascular Endothelial Growth Factor Therapy in the Treatment of Proliferative Diabetic ...

Figures and Tables from this paper - Semantic Scholar

Review of Studies Comparing Panretinal Photocoagulation and Anti-Vascular Endothelial Growth Factor Therapy in the Treatment of Proliferative Diabetic ...

Laser Therapy in the Treatment of Diabetic Retinopathy and ...

This article focuses on the use of peripheral scatter retinal laser (e.g., panretinal photocoagulation, or PRP) to treat PDR and the use of ...

Pan-retinal photocoagulation and other forms of laser treatment and ...

The risk of severe visual loss after 5 years for eyes assigned to PRP for NPDR or early PDR compared with deferral of PRP was reduced by 23% (relative risk 0.77 ...